ScholarLens Back to search
2005•International ImmunopharmacologyRequires access

Involvement of nitric oxide in anti-tumor effects of OK-432, a streptococcal anti-tumor immunotherapeutic agent

Tetsuya Oshikawa, Masato Okamoto, Tomoyuki Tano, Sharif Ahmed, Akiko Sasai, Shin Kan, Yoichiro Moriya, Yoshiki Ryoma, Motoo Saito, Mitsunobu Sato

Open publisher page 5 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 5 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Splenocyte, Tumor necrosis factor alpha, Cytotoxicity, In vivo, Nitric oxide, Nitric oxide synthase, In vitro, Interferon

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Involvement of nitric oxide in anti-tumor effects of OK-432, a streptococcal anti-tumor immunotherapeutic agent — Research Paper | ScholarLens